肿瘤相关性睡眠障碍的研究进展  

The Research Progress of Cancer-related Sleep Disturbance

作　　者：赖小英[1] 陈丽君[1] LAI Xiaoying;CHEN Lijun(Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China)

机构地区：[1]广西医科大学附属肿瘤医院,南宁530021

出　　处：《世界睡眠医学杂志》2022年第1期183-186,共4页World Journal of Sleep Medicine

摘　　要：肿瘤相关睡眠障碍发生率较高,可发生在肿瘤治疗前或治疗过程中的任何阶段,甚至在肿瘤治疗结束后仍长期存在,不仅可影响患者的日常功能,降低患者的生命质量,甚至影响预后降低肿瘤患者的生存率。本文就肿瘤相关睡眠障碍的流行病学、发病机制、影响因素及非药物治疗方法进行综述,为减轻肿瘤患者睡眠障碍的程度、降低肿瘤患者睡眠障碍的发生率、提高肿瘤患者的生命质量提供理论基础。The incidence of tumor-related sleep disorders is high,which can occur at any stage before or during tumor treatment,and even exist for a long time after the completion of tumor treatment.It can not only affect the daily function,reduce the quality of life of patients,but also affect the prognosis and reduce the survival rate of patients with cancer.In this paper,the epidemiology,pathogenesis,influencing factors and non-drug therapy of tumor-related sleep disorders were reviewed to provide a theoretical basis for reducing the degree,incidence of cancer-related sleep disorders and proving quality of patients′life.

关 键 词：癌症 睡眠障碍 流行病学 发病机制 非药物治疗 

分 类 号：R730.6[医药卫生—肿瘤]